secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0000950170-25-065680
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical Q1 revenue up 6%, gross margin expands to 37.2%, net loss narrows
--------------------------------------------------------------------------------

- Net revenue $29.8M (+6% YoY); recurring Tablo consumables & services $22.7M (+20% YoY).
- Gross margin 37.2% (non-GAAP 37.6%), up from 29.2% in Q1 2024; product margin 48.3%.
- Net loss $25.8M (-$3.66/share) vs. $39.9M (-$11.77) a year ago; operating cash use down 44%.
- Reiterated FY2025 guidance: revenue $115M-$125M, non-GAAP gross margin high-30% range, cash use < $50M.
- Tariff exemption confirmed under USMCA and for chronically disabled; no expected impact.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000095017025065680/0000950170-25-065680-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000095017025065680/om-20250507.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-065680

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer